'Critical gaps' in breast cancer research

'Critical gaps' in breast cancer research

Critical gaps in breast cancer research could see the loss of around 185,000* lives by 2030 if they are not urgently addressed, according to a major new study co-authored by researchers from King's College London.

Globally, is the most frequently diagnosed cancer in , with an estimated 1.38 million new cases per year. 50,000 cases in women and 400 in men are recorded each year in the UK alone.

Published today by Breast Cancer Campaign, the research brought together more than 100 internationally recognised scientists, clinicians and healthcare professionals, along with patient advocates, to explore which gaps in research, if filled, would bring the greatest patient benefits.

The gaps range from identifying lifestyle changes which could enable women to protect themselves from the disease to a better understanding of how tumours grow and spread to other parts of the body.

Some of the gaps concern the need for new treatments – particularly for secondary or , where the tumour spreads to other parts of the body. There is a need for biopsies, ortissue samples, to be taken from these secondary cancers, because they are often not the same as the primary cancer, according to the researchers.

Further research is needed to understand what it is that enables to become resistant to drugs and to spread throughout the body.

A better understanding of prevention is also required to identify which sustainable changes in lifestyle, such as diet and exercise, can reduce a woman's chance of developing cancer in the first place.

More information: breast-cancer-research.com/content/15/5/R92

Related Stories

Breast cancer research highlights gaps

date Oct 02, 2013

(Medical Xpress)—Research involving a Newcastle University academic has identified the ten critical gaps that exist in breast cancer research, which if not urgently addressed could see the loss of around 185,000 lives by ...

Alternative target for breast cancer drugs

date Jul 19, 2013

Scientists have identified higher levels of a receptor protein found on the surface of human breast tumour cells that may serve as a new drug target for the treatment of breast cancer. The results, which are published today ...

Fragile X syndrome protein linked to breast cancer progression

date Sep 18, 2013

A research team led by scientists from VIB/KU Leuven, Belgium, and the University of Rome Tor Vergata, Italy, in collaboration with several research centers and hospitals in Italy, the United Kingdom and, Belgium, has identified ...

Recommended for you

Spicy treatment the answer to aggressive cancer?

date Jul 03, 2015

It has been treasured by food lovers for thousands of years for its rich golden colour, peppery flavour and mustardy aroma…and now turmeric may also have a role in fighting cancer.

Cancer survivors who smoke perceive less risk from tobacco

date Jul 02, 2015

Cancer survivors who smoke report fewer negative opinions about smoking, have more barriers to quitting, and are around other smokers more often than survivors who had quit before or after their diagnosis, according to a ...

Melanoma mutation rewires cell metabolism

date Jul 02, 2015

A mutation found in most melanomas rewires cancer cells' metabolism, making them dependent on a ketogenesis enzyme, researchers at Winship Cancer Institute of Emory University have discovered.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.